Evidence map›Paper›PMID 34928817›Full record

ArticleAging2021

NAD+ improved experimental autoimmune encephalomyelitis by regulating SIRT1 to inhibit PI3K/Akt/mTOR signaling pathway.

Jinli Wang, Xueqin Song, Guojun Tan, Pengtao Sun, Li Guo, Ning Zhang, Jueqiong Wang, Bin Li

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Sirtuin family in autoimmune diseases.Frontiers in immunology · 2023
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jinli WangDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei, China.
Xueqin SongDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei, China.
Guojun TanDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei, China.
Pengtao SunDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei, China.
Li GuoDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei, China.
Ning ZhangDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei, China.
Jueqiong WangDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei, China.
Bin LiDepartment of Neurology, The Second Hospital of Hebei Medical University, Key Laboratory of Hebei Neurology, Shijiazhuang 050051, Hebei, China.
Hebei Medical University · CNSecond Hospital of Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effect of NAD+ on thymus autophagy in experimental autoimmune encephalomyelitis (EAE) mice through SIRT1.

methodsBioinformatic analysis was used to identify hub genes. Forty female C57BL/6 mice were randomly divided into 4 groups: control, EAE, NAD+, and NAD+ +SIRT1 inhibitor (SIRT-IN-3) groups and SIRT1 group. The NAD+ group and SIRT1 inhibitor group were treated with NAD+ drug and fed for 4 weeks. The neurological function scores were evaluated weekly. The thymus tissues of wild-type mice were removed, ground and filtered into single-cell suspension. MOG 35-55 (1 μg/mL) was given to primary thymic epithelial cells (TECs) to induce EAE model

resultsEnrichment analysis showed PI3K-Akt-mTOR and autophagy pathway were main terms in EAE diseases, and the relationship between NAD+ and SIRT1. The activation of p-PI3K, p-Akt and p-mTOR were the highest in the EAE group consistent with decreased P62, Beclin1, LC-3A/B and SIRT1, and NAD+ reversed these results, furthermore SIRT1 inhibitor: SIRT-IN3 weakened the NAD+' effects in both

conclusionsNAD+ exerted a protective effect on EAE mice by inhibiting PI3K/Akt/mTOR signaling pathway through SIRT1 in TECs, and prevented EAE mice from sustained damage.

Indexed as

AnimalsAutophagyDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalFemaleMiceMice, Inbred C57BLNADPhosphatidylinositol 3-KinasesPhosphorylationProto-Oncogene Proteins c-aktSignal TransductionSirtuin 1Thymus GlandTOR Serine-Threonine KinasesmTOR protein, mouseNADPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSirt1 protein, mouseSirtuin 1TOR Serine-Threonine KinasesbioinformaticsimmunoregulationNAD+SIRT1thymic epithelial cellsthymus autophagy

Identifiers

PMID34928817
PMCPMC8751589
OpenAlexW4226179888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.